Involvement of interleukin-1β in systemic morphine effects on paw oedema in a mouse model of acute inflammation

Scandinavian Journal of Immunology

Volumn 59, Issue 3, 2004, Pages 273-277

  Pourpak, Z ^a   Ahmadiani, A ^b   Alebouyeh, M ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; INTERLEUKIN 1BETA; MORPHINE SULFATE; NALOXONE; ANTIINFLAMMATORY AGENT; INTERLEUKIN 1; MORPHINE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; TIME SERIES ANALYSIS; ANIMAL; BLOOD; DISEASE MODEL; DRUG ANTAGONISM; EDEMA; HINDLIMB; IMMUNOLOGY; MOUSE;

ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DISEASE MODELS, ANIMAL; EDEMA; HINDLIMB; INFLAMMATION; INTERLEUKIN-1; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS;

EID: 1842505194     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01396.x     Document Type: Article

References (25)

1. Stein C, Hassan AH, Ryzewlocki R, Gramsch C, Peter K, Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990;87:5935-9.
2. Wilson JL, Nayanar V, Walker JS. The site of anti-arthritic action of the κ-opioid, u-50, 488, in adjuvant arthritis: importance of local administration. Br J Pharmacol 1996;118:1754-60.
3. Tsai YC, Won SJ, Lin MT. Effects of morphine on immune response in rats with sciatic constriction injury. Pain 2000;88:153-60.
4. Walker JS, Chandler AK, Wilson JL, Binder W, Day RO. Effects of mu opioids morphine and buprenorphine on the development of adjuvant arthritis in rats. Inflamm Res 1996;45:557-63.
5. Valle L, Puig MM, Pol O. Effects of mu-opioid receptor agonists on intestinal secretion and permeability during acute intestinal inflammation in mice. Eur J Pharmacol 2000;18:235-42.
6. Puig MM, Pol O. Peripheral effects of opioids in a model of chronic intestinal inflammation in mice. J Pharmacol Exp Ther 1998;287:1068-75.
7. Joris J, Costello A, Dubner R, Hargreaves KM. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 1990;43:95-103.
8. Perrot S, Guilbaud G, Kayser V. Effects of intraplantar morphine on paw edema and pain-related behavior in a rat model of repeated acute inflammation. Pain 1999;83:249-57.
9. Alebouyeh M, Pourpak Z, Ahmadiani A. Increase in serum level of interleukin-1 alpha mediates morphine anti-inflammatory effect in carrageenan-induced paw oedema in mice. Cytokine 2002;19: 102-5.
10. Dinarello CA. Modalities for reducing interleukin-1 activity in disease. Immunol Today 1993;14:260-3.
11. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 1983;16:109-10.
12. Fereidoni M, Ahmadiani A, Semnanian S, Javan M. An accurate and simple method for measurement of paw edema. J Pharmacol Toxicol Methods 2000;43:1-14.
13. Sengupta JN, Snider A, Su X, Gebhart GF. Effects of kappa opioids in the inflamed rat colon. Pain 1999;79:175-85.
14. Jessop DS, Major GN, Coventry TL et al. Novel opioid peptides endomorphine-1 and endomorphine-2 are present in mammalian immune tissues. J Neuroimmunol 2000;106:53-9.
15. Mousa SA, Schafer M, Mitchell WM, Hassan AHS, Stein C. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in tats with painful hindlimb inflammation. Eur J Pharmacol 1996;311:221-31.
16. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995;63:289-302.
17. Amann R, Lanz I, Schuligoi R. Effects of morphine on oedema and tissue concentration of nerve growth factor in experimental inflammation of the rat paw. Pharmacology 2002;66:169-72.
18. Chang SL, Wu GD, Patel NA, Vidal EL, Fiala M. The effects of interaction between morphine and interleukin-1 on the immune response. Adv Exp Med Biol 1998;437:67-72.
19. Crain SM, Shen KF. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, Gm1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 1998;19:358-65.
20. Van de loo FA, Arntz OJ, Van Enckevort FH, Van Lent PL, Van den Berg WB. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1 treated wild-type mice with unabated joint inflammation. Arthritis Rheum 1998;41:4634-46.
21. Ma XC, Chen LT, Oliver J, Horvath E, Phelps CP. Cytokine and adrenal axis responses to endotoxin. Brain Res 2000;861:135-42.
22. Loreto D, Corvetti R, Maccarone R, Piancatelli D, Adorno D. Interleukin 1-beta modulates the effects of hypoxia in neuronal culture. J Neuroimmunol 2000;106:32-42.
23. Jeanjean AP, Moussaoui SM, Maloteaux JM, Laduron PM. Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 1995;68:151-7.
24. Schafer M, Carter L, Stein C. Interleukin-1β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994;91:4219-23.
25. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon R, Goodman Gilman A, eds. Goodman and Gillmans. The Pharmacological Basis of Therapeutics. Vol 59. New York: McGraw-Hill Press, 1996, 619.